Trial of blood glucose control and QOL change by sensor augmented pump (SAP) therapy and low glucose suspend (LGS)

Trial of blood glucose control and QOL change by sensor augmented pump (SAP) therapy and low glucose suspend (LGS) - Trial of blood glucose control and QOL change by SAP

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000037028

Enrollment

Registered

2019-06-14

Start date

2018-12-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 diabetes mellitus

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inpatient or outpatient Patients of Diabetology and Metabolism, Tokyo Women's Medical University Hospital. 20 years old or older at the time of obtaining consent Diagnosed with type 1 diabetes and start SAP newly. Obtained written informed consent.

Exclusion criteria

Exclusion criteria: Undergoing hemodialysis Severe renal failure (eGFR less than 30 ml/min/1.73m2) Pregnant or potential patients Patients who the research director judged as inappropriate as subjects.

Design outcomes

Primary

Measure	Time frame
Change in glycemic control	—

Secondary

Measure	Time frame
QOL, body weight, BMI, insulin dose, frequency of SMBG, hypoglycemia, severe hypoglycemia, and LGS function	—

Countries

Japan

Contacts

Public ContactSatoshi Takagi

Tokyo Women's Medical university Diabetology and Metabolism

takagi.satoshi.dmc@twmu.ac.jp03-3353-8111

Outcome results